Sector
PharmaceuticalsOpen
₹5.5Prev. Close
₹5.75Turnover(Lac.)
₹0Day's High
₹5.5Day's Low
₹5.552 Week's High
₹052 Week's Low
₹0Book Value
₹-148.61Face Value
₹10Mkt Cap (₹ Cr.)
34.04P/E
0EPS
0Divi. Yield
0No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
Equity Capital | 87.89 | 87.89 | 87.89 | 87.89 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -934.22 | -877.22 | -769.15 | -283.96 |
Net Worth | -846.33 | -789.33 | -681.26 | -196.07 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
Revenue | 72.6 | 73.72 | 75.59 | 231.78 |
yoy growth (%) | -1.52 | -2.47 | -67.38 | -47.07 |
Raw materials | -63.48 | -91.94 | -328.51 | -255.83 |
As % of sales | 87.44 | 124.71 | 434.57 | 110.37 |
Employee costs | -9.3 | -8.46 | -10.67 | -17.01 |
| Y/e 31 Mar( In .Cr) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
Profit before tax | -55.24 | -105.01 | -480.75 | -248.99 |
Depreciation | -34.53 | -53.48 | -67.05 | -72.96 |
Tax paid | -1.75 | -3.05 | -4.43 | -130.32 |
Working capital | -15.37 | -43.6 | -399 | -76.64 |
Other operating items |
| Y/e 31 Mar | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -1.52 | -2.47 | -67.38 | -47.07 |
Op profit growth | -64.11 | -85.02 | 289.89 | -3.6 |
EBIT growth | -50.69 | -74.51 | 148.24 | 9.75 |
Net profit growth | -47.25 | -77.72 | 27.9 | 187.94 |
| Particulars (Rupees in Crores.) | Mar-2018 | Mar-2017 | Mar-2016 | Mar-2015 | Mar-2014 |
|---|---|---|---|---|---|
Gross Sales | 72.35 | 70.3 | 84.34 | 240.3 | 446.7 |
Excise Duty | 0 | 0 | 8.88 | 11.15 | 16.32 |
Net Sales | 72.35 | 70.3 | 75.46 | 229.15 | 430.36 |
Other Operating Income | 0.81 | 4.6 | 1.7 | 4.24 | 20.25 |
Other Income | 4.16 | 6.19 | 0 | 0 | 26.97 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Pranav Gupta
Whole-time Director
Vineet Gupta
Independent Director
Jagjit Singh Chahal
Independent Director
Vandana Singla
Independent Director
Sanjeev Kumar
SCO 186-187 2nd Floor,
Sector 8c,
Chandigarh - 160008
Tel: 91-0172-4182800
Website: http://www.parabolicdrugs.com
Email: [email protected]
Narang Tower,
44 Community Centre, Naraina Ind Area,
New Delhi-110028
Tel: 91-11-41410592-94
Website: www.linkintime.co.in
Email: [email protected]
Summary
Parabolic Drugs Ltd is one of the fast growing API (Active Pharmaceutical Ingredients) and API intermediate manufacturing and marketing company. The company is in SME segment, with increasing internat...
Read More
Reports by Parabolic Drugs Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.